Merck's Experimental Anti- Covid Pill 'Molflu' To Cost Rs 35 In India

Molnupiravir will be sold under brand name 'Molflu' and will be priced it at 35 rupees per capsule.

Drugmaker Dr Reddy's Laboratories Ltd will launch its generic version of Merck's antiviral COVID-19 pill, molnupiravir, under brand name 'Molflu' and will price it at 35 rupees per capsule, a company spokesperson said on Tuesday.

(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)